A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...
This study will enroll HIV-infected people who do not have evidence of active TB but who are at high risk of developing active...
The study is being done with people who are taking their first anti-HIV drug regimen (including an Non-Nucleoside Reverse...
A single dose of nevirapine (SD NVP) given to an HIV infected pregnant woman followed by a single dose to her infant has been...
TB is a major cause of illness and death in women of reproductive age. Pregnant and postpartum women with latent TB are at...
